Our Pharmaceutical
Product Portfolio

APR's in-house team of global product development experts is strongly committed to delivering optimal clinical outcomes while enriching patients’ quality of life to ensure the best of care and support optimal management of both the patient and the disease.

We work closely with healthcare professionals, patients and caregivers dealing with rare and orphan diseases in order to better understand still unsolved needs and desired therapeutic benefit, which then become our compass throughout the development journey.

Our Patented Technology Platforms

All our products are based on proprietary technology platforms that provide unique treatment options to patients and healthcare professionals by offering improved efficacy, safety or patient convenience (i.e. compliance) for patients' enriched quality of life.

APR’s main patented technology platforms are the following:

Physiomimic® Technology, a pharmaceutical technology, which for the first time has been applied to a medical food for PKU dietary management, PKU GOLIKE®, which allows the production of special coating granules with amino acids, for better compliance and metabolic management.

TEHCLO®, a patented nanotechnology, ensuring the highest quality in the production of hypochlorous acid (HClO) solution for various health applications, such as Nexodyn®, the wound cleanser for advanced chronic wound care.

Dynamic Buffering Technology, DBT, enabling an Immediate Release formulation of Diclofenac K (a proven non-steroidal anti-inflammatory drug – NSAID) based on a unique blend of Diclofenac and bicarbonate for a faster absorption and onset of action in comparison with conventional preparation, ensuring a more effective acute pain management and an exceptionally fast pain relief.

Learn more about our prescription healthcare products and our consumer healthcare products !